Sally is co-founder and Executive Chairman of CP2. Sally is focused on developing the investment philosophy and values of CP2 since 1997. Sally has over 20 years experience in investment execution and operating investment portfolios for the long-term investor and is an advocate of responsible corporate governance. She is also a member of the CP2 Investment Committee and Human Capital Committee. Sally is a board member of the Melanoma Institute Australia and a graduate member of the Australian Institute of Company Directors.